Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
Censoring Survival Data01:09

Censoring Survival Data

217
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
217
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

246
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
246
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

276
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
276
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

190
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
190
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

378
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
378

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Chinese Herbal Medicine on Pregnancy Outcomes in IVF Patients with Low Ovarian Reserve: A Predictive Model.

Medicina (Kaunas, Lithuania)·2025
Same author

Government subsidy for infertility treatment: Impact on quality of life for infertile women undergoing in vitro fertilization-embryo transfer.

Journal of the Formosan Medical Association = Taiwan yi zhi·2024
Same author

Analysis of recurrent event data with spatial random effects using a Bayesian approach.

Statistical methods in medical research·2024
Same author

Efficient estimation of a Cox model when integrating the subgroup incidence rate information.

Journal of applied statistics·2023
Same author

Effect of atosiban on in vitro fertilization pregnancy outcome among women with endometriosis in presence or absence of adenomyosis.

Taiwanese journal of obstetrics & gynecology·2023
Same author

Risk Factors for QT Prolongation in Patients with Chronic Hydroxychloroquine Use.

Acta Cardiologica Sinica·2022

Related Experiment Video

Updated: Sep 4, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Evaluating response-adaptive randomization procedures for recurrent events and terminal event data using a composite

Yu-Lin Mau1, Pei-Fang Su1

  • 1Department of Statistics, National Cheng Kung University, Tainan, Taiwan.

Pharmaceutical Statistics
|July 19, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces response adaptive randomization using a composite endpoint for recurrent and terminal events. The new method ethically allocates more participants to superior treatments, reducing exposure to inferior ones.

Keywords:
allocation rulebalanced randomizationdoubly adaptive biased coin designfisher information matrix

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Sep 4, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Recurrent and terminal events are common in clinical studies.
  • Composite endpoints are useful for evaluating treatment efficacy, especially in costly, long-term studies.
  • Joint frailty modeling is a standard approach for analyzing recurrent event data with a terminal event.

Purpose of the Study:

  • To develop target-driven response adaptive randomization strategies for clinical trials.
  • To utilize a composite endpoint based on joint frailty modeling for improved treatment allocation.
  • To enhance ethical considerations in clinical trials by minimizing patient exposure to suboptimal treatments.

Main Methods:

  • Implementation of a balanced randomized design as a baseline.
  • Investigation of response adaptive randomization strategies.
  • Application of joint frailty modeling for composite endpoints involving recurrent and terminal events.

Main Results:

  • The proposed response adaptive randomization procedures effectively reduce the number of participants receiving inferior treatment.
  • The strategies achieve desired optimal treatment targets compared to traditional balanced randomization.
  • An R Shiny application is available for sample size calculation and allocation probabilities.

Conclusions:

  • Response adaptive randomization with composite endpoints offers an ethical and efficient approach to clinical trial design.
  • These methods are particularly beneficial for studies with recurrent and terminal events.
  • The developed procedures provide a practical tool for optimizing treatment allocation in clinical research.